Mar 27, 2017 20:05 pm UTC| Business
Weichai America Corp. to invest $60 million in Power Solutions Significantly strengthens Power Solutions financial position with new equity capital and establishes substantial strategic growth and cost savings...
Aquinox Announces Appointment of Dr. Kelvin Neu and Dr. Richard Levy to Board of Directors
Mar 27, 2017 20:05 pm UTC| Business
VANCOUVER, British Columbia, March 27, 2017 -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of...
Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors
Mar 27, 2017 20:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 27, 2017 -- Fluidigm Corporation (NASDAQ:FLDM) today announced that Nicolas Barthelemy and Dr. Carlos Paya have been appointed to its Board of Directors. Barthelemy brings over 25...
Ocera to Present at the 16th Annual Needham Healthcare Conference
Mar 27, 2017 20:05 pm UTC| Business
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., March 27, 2017 -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
TRACON Pharmaceuticals Announces TRC694 Data Presentation at Upcoming AACR Annual Meeting
Mar 27, 2017 20:05 pm UTC| Business
SAN DIEGO, March 27, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
Mar 27, 2017 20:04 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 27, 2017 -- Calithera Biosciences, Inc. (NASDAQ:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor...
Threshold Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 27, 2017 20:02 pm UTC| Business
-- Recently proposed merger with Molecular Templates will result in Nasdaq-listed company focused on developing novel treatments for cancer -- SOUTH SAN FRANCISCO, Calif., March 27, 2017 -- Threshold Pharmaceuticals,...